Effect of anesthesia strategy during endovascular therapy on 90-day outcomes in acute basilar artery occlusion: a retrospective observational study

Table 2 Comparison of 90-day outcome between patients under GA and CS

Outcome variable	GA	CS	Univariate analysis		Multivariable analysis
			Univariate analysis		Model 1		Model 2		Model 3
			cOR (95% CI)	P value	aOR (95% CI)	P value	aOR (95% CI)	P value	aOR (95% CI)	P value
Functional independence (mRS 0–2) at 90 days	43/139 (30.9)	24/39 (61.5)	0.28(0.13–0.59)	< 0.01	0.31(0.13–0.75)	0.01	0.29 (0.09–0.97)	0.045	0.31(0.10–0.97)	0.045 *
Favorable outcome (mRS 0–3) at 90 days	60/139 (43.2)	30/39 (76.9)	0.23(0.10–0.52)	< 0.01	0.26(0.10–0.64)	< 0.01	0.25 (0.07–0.83)	0.02	0.24(0.07–0.75)	0.02 †
Death at 90 days	29/139 (20.9)	3/39 (7.7)	3.16(0.91–11.01)	0.07	2.57(0.70–9.52)	0.16	3.36 (0.48–23.68)	0.22	2.99(0.46–19.74)	0.25 ‡

Model 1 adjusted for age, sex, from vascular occlusion to puncture, NIHSS score
Model 2 adjusted for age, sex, from vascular occlusion to puncture, NIHSS score, previous ischemic stroke, Mode of stroke onset, Blood glucose, Use of Solitaire retriever, Infusion of Tirofiban, Angioplasty
GA indicates general anesthesia, CS conscious sedation, cOR crude odds ratio, aOR adjusted odds ratio, CI confidence interval, mRS modified Rankin Scale
*Adjusted for age, sex, from vascular occlusion to puncture, NIHSS score, previous ischemic stroke, angioplasty, anesthesia time
†Adjusted for age, sex, from vascular occlusion to puncture,NIHSS score, use solitaire retriever, blood glucose, anesthesia time
‡Adjusted for age, sex, from vascular occlusion to puncture, NIHSS score, previous ischemic stroke, blood glucose, use of solitaire, angioplasty, anesthesia time

ISSN: 1471-2377